{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:27:25Z","timestamp":1793820445935,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T00:00:00Z","timestamp":1729382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["031L0308A"],"award-info":[{"award-number":["031L0308A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2014_Kolleg.05"],"award-info":[{"award-number":["2014_Kolleg.05"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["EXC2151-390685813"],"award-info":[{"award-number":["EXC2151-390685813"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["EXC2047-390873048"],"award-info":[{"award-number":["EXC2047-390873048"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.humpath.2024.105670","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T15:32:11Z","timestamp":1728833531000},"page":"105670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Expression of the large amino acid transporter SLC7A5\/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6182-835X","authenticated-orcid":false,"given":"Vittorio","family":"Branchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Racha","family":"Hosni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kiwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"van der Voort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neila","family":"Bambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Kleinfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Dold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Langhans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Gonzalez-Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg C.","family":"Kalff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Thurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Matthaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-3712","authenticated-orcid":false,"given":"Marieta I.","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humpath.2024.105670_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bpg.2015.02.006","article-title":"Pathologic classification of cholangiocarcinoma: new concepts","volume":"29","author":"Nakanuma","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105670_bib2","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.humpath.2024.105670_bib3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.26890","article-title":"Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncol"},{"issue":"8","key":"10.1016\/j.humpath.2024.105670_bib5","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.humpath.2014.03.014","article-title":"Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma","volume":"45","author":"Graham","year":"2014","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2024.105670_bib6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma","volume":"43","author":"Kipp","year":"2012","journal-title":"Hum Pathol"},{"issue":"17","key":"10.1016\/j.humpath.2024.105670_bib7","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.humpath.2024.105670_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"issue":"25","key":"10.1016\/j.humpath.2024.105670_bib9","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.humpath.2024.105670_bib10","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/cncr.31942","article-title":"Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013","volume":"125","author":"Van Dyke","year":"2019","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.humpath.2024.105670_bib11","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.3390\/curroncol29070402","article-title":"Intensive follow-up program and oncological outcomes of biliary tract cancer patients after curative-intent surgery: a twenty-year experience in a single tertiary medical center","volume":"29","author":"Rizzo","year":"2022","journal-title":"Curr Oncol"},{"issue":"9","key":"10.1016\/j.humpath.2024.105670_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5009\/gnl18105","article-title":"Incidence and overall survival of biliary tract cancers in South Korea from 2006 to 2015: using the national health information database","volume":"13","author":"Kim","year":"2019","journal-title":"Gut Liver"},{"issue":"14","key":"10.1016\/j.humpath.2024.105670_bib14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.humpath.2024.105670_bib15","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Do-Youn","year":"2022","journal-title":"NEJM Evidence."},{"issue":"5","key":"10.1016\/j.humpath.2024.105670_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105670_bib17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/cancers14061442","article-title":"Molecular mechanisms linking risk factors to cholangiocarcinoma development","volume":"14","author":"Ceci","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.humpath.2024.105670_bib18","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.humpath.2024.105670_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0030-1253227","article-title":"The role of inflammation in cholestasis \u2013 clinical and basic aspects","volume":"30","author":"Kosters","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.humpath.2024.105670_bib20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.20966","article-title":"Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells","volume":"42","author":"Isomoto","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.humpath.2024.105670_bib21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.31110","article-title":"Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals therapeutic opportunities","volume":"72","author":"Goeppert","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.humpath.2024.105670_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/path.5994","article-title":"Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis","volume":"258","author":"Kamp","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2024.105670_bib23","article-title":"The human SLC7A5 (LAT1): the intriguing histidine\/large neutral amino acid transporter and its relevance to human health","volume":"6","author":"Scalise","year":"2018","journal-title":"Frontiers in Chemistry [Internet]"},{"issue":"12","key":"10.1016\/j.humpath.2024.105670_bib24","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1349-7006.2008.00969.x","article-title":"l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms","volume":"99","author":"Kaira","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2024.105670_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1471-2407-13-482","article-title":"Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer","volume":"13","author":"Kaira","year":"2013","journal-title":"BMC Cancer"},{"issue":"1.2","key":"10.1016\/j.humpath.2024.105670_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2152\/jmi.70.160","article-title":"Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma","volume":"70","author":"Selenge","year":"2023","journal-title":"J Med Invest"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12935-023-02957-z","article-title":"Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells","volume":"23","author":"Nishikubo","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.humpath.2024.105670_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.21037\/gs-21-909","article-title":"A comprehensive analysis of the diagnostic and prognostic value associated with the SLC7A family members in breast cancer","volume":"11","author":"Yan","year":"2022","journal-title":"Gland Surg"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/or.2021.8228","article-title":"SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen-receptor-positive breast cancer","volume":"47","author":"T\u00f6rnroos","year":"2022","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2024.105670_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108987","article-title":"SLC7A5 expression is up-regulated in peripheral blood T and B lymphocytes of systemic lupus erythematosus patients, associating with renal damage","volume":"237","author":"Tian","year":"2022","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105670_bib31","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.3390\/ijms23073637","article-title":"Functional characterization of the solute carrier LAT-1 (SLC7A5\/SLC2A3) in human brain capillary endothelial cells with rapid UPLC-MS\/MS quantification of intracellular isotopically labelled L-leucine","volume":"23","author":"Bay","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.humpath.2024.105670_bib32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10637-020-00924-3","article-title":"First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors","volume":"38","author":"Okano","year":"2020","journal-title":"Invest N Drugs"},{"issue":"8","key":"10.1016\/j.humpath.2024.105670_bib33","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1038\/s41596-021-00556-8","article-title":"CODEX multiplexed tissue imaging with DNA-conjugated antibodies","volume":"16","author":"Black","year":"2021","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-019-3055-3","article-title":"Cytokit: a single-cell analysis toolkit for high dimensional fluorescent microscopy imaging","volume":"20","author":"Czech","year":"2019","journal-title":"BMC Bioinf"},{"issue":"1\u20132","key":"10.1016\/j.humpath.2024.105670_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jemt.20092","article-title":"Complex wavelets for extended depth\u2010of\u2010field: a new method for the fusion of multichannel microscopy images","volume":"65","author":"Forster","year":"2004","journal-title":"Microsc Res Tech"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14836","article-title":"A BaSiC tool for background and shading correction of optical microscopy images","volume":"8","author":"Peng","year":"2017","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.humpath.2024.105670_bib37","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1093\/bioinformatics\/btac544","article-title":"Stitching and registering highly multiplexed whole-slide images of tissues and tumors using ASHLAR","volume":"38","author":"Muhlich","year":"2022","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation","volume":"18","author":"Stringer","year":"2020","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105670_bib40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.humpath.2024.105670_bib41","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.humpath.2024.105670_bib42","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"20","key":"10.1016\/j.humpath.2024.105670_bib43","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.3390\/cancers15204947","article-title":"Primary sclerosing cholangitis-associated cholangiocarcinoma: from pathogenesis to diagnostic and surveillance strategies","volume":"15","author":"Catanzaro","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.humpath.2024.105670_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.humpath.2024.105670_bib45","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","article-title":"Amino acid transporters in cancer and their relevance to \u201cglutamine addiction\u201d: novel targets for the design of a new class of anticancer drugs","volume":"75","author":"Bhutia","year":"2015","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.humpath.2024.105670_bib46","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/febs.14577","article-title":"Glucose transporters in cancer \u2013 from tumor cells to the tumor microenvironment","volume":"285","author":"Ancey","year":"2018","journal-title":"FEBS J"},{"issue":"8","key":"10.1016\/j.humpath.2024.105670_bib47","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.4049\/jimmunol.1300923","article-title":"LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells","volume":"191","author":"Hayashi","year":"2013","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.humpath.2024.105670_bib48","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.4049\/jimmunol.180.7.4476","article-title":"Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways","volume":"180","author":"Jacobs","year":"2008","journal-title":"J Immunol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T13:41:53Z","timestamp":1732196513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":48,"alternative-id":["S0046817724001795"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105670","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of the large amino acid transporter SLC7A5\/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 University Hospital Bonn, Institute of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105670"}}